🇦🇺 Australia Country × Condition
gastric cancer Clinical Trials in Australia
Active clinical trials for gastric cancer with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1, Phase 2, Phase 1 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇦🇺 Australia
Active Trials in Australia (5)
NCT05086692 Phase 1, Phase 2
Recruiting
A Beta-only IL-2 ImmunoTherapY Study
Enrollment
115 pts
Country
🇦🇺 Australia
Medicenna Therapeutics, Inc.
View Trial → NCT05872295 Phase 1
Recruiting
IKS014 in Advanced Solid Tumors That Express HER2
Enrollment
165 pts
Country
🇦🇺 Australia
Iksuda Therapeutics Ltd.
View Trial → NCT06337084 Phase 1
Recruiting
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
Enrollment
12 pts
Country
🇦🇺 Australia
Monopar Therapeutics
View Trial → NCT06617169 Phase 1
Recruiting
Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors
Enrollment
12 pts
Country
🇦🇺 Australia
Monopar Therapeutics
View Trial → NCT05427487 Phase 1
Recruiting
Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours
Enrollment
70 pts
Country
🇦🇺 Australia
ImmVirx Pty Ltd
View Trial → Frequently Asked Questions
How many gastric cancer clinical trials are active in Australia?
There are currently 5 active clinical trials for gastric cancer with sites in Australia, of which 5 are actively recruiting patients.
How can I join a gastric cancer clinical trial in Australia?
To join a gastric cancer clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are gastric cancer trials in Australia?
Active gastric cancer trials in Australia span Phase 1, Phase 2, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology